Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Orli Even-Or, Sarit Samira, Ronald Ellis, Eli Kedar & Yechezkel Barenholz. (2013) Adjuvanted influenza vaccines. Expert Review of Vaccines 12:9, pages 1095-1108.
Read now
Read now
Christian Moser, Matthias Müller, Matthias D Kaeser, Ulrike Weydemann & Mario Amacker. (2013) Influenza virosomes as vaccine adjuvant and carrier system. Expert Review of Vaccines 12:7, pages 779-791.
Read now
Read now
Farzin Roohvand & Niloufar Kossari. (2012) Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities. Expert Opinion on Therapeutic Patents 22:4, pages 391-415.
Read now
Read now
Christian Moser, Mario Amacker & Rinaldo Zurbriggen. (2011) Influenza virosomes as a vaccine adjuvant and carrier system. Expert Review of Vaccines 10:4, pages 437-446.
Read now
Read now
Joel R Haynes. (2009) Influenza virus-like particle vaccines. Expert Review of Vaccines 8:4, pages 435-445.
Read now
Read now
Claudia A Daubenberger, Gerd Pluschke, Rinaldo Zurbriggen & Nicole Westerfeld. (2008) Development of influenza virosome-based synthetic malaria vaccines. Expert Opinion on Drug Discovery 3:4, pages 415-423.
Read now
Read now
Articles from other publishers (60)
Francisco Noé Fonseca, Vanessa Haach, Franciana Volpato Bellaver, Gabrielly Bombassaro, Danielle Gava, Luciano Paulino da Silva, Lana Flavia Baron, Mayara Simonelly, Wanessa Araújo Carvalho, Rejane Schaefer & Ana Paula Bastos. (2023) Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine. Virology Journal 20:1.
Crossref
Crossref
Dhruv N. Desai, Ahmed Mahal, Rajat Varshney, Ahmad J. Obaidullah, Bhawna Gupta, Pratikhya Mohanty, Priyabrata Pattnaik, Nrusingha Charan Mohapatra, Snehasish Mishra, Venkataramana Kandi, Ali A. Rabaan & Ranjan K. Mohapatra. (2023) Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation. ACS Omega 8:31, pages 27953-27968.
Crossref
Crossref
Toon Stegmann, Anna-Sophia Wiekmeijer, Kitty Kwappenberg, Suzanne van Duikeren, Farien Bhoelan, Denzel Bemelman, Thomas J. M. Beenakker, Willem-Jan Krebber, Ramon Arens & Cornelis J. M. Melief. (2023) Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides. Cancer Immunology, Immunotherapy 72:8, pages 2851-2864.
Crossref
Crossref
Gerrit Koopman, Mario Amacker, Toon Stegmann, Ernst J. Verschoor, Babs E. Verstrepen, Farien Bhoelan, Denzel Bemelman, Kinga P. Böszörményi, Zahra Fagrouch, Gwendoline Kiemenyi-Kayere, Daniella Mortier, Dagmar E. Verel, Henk Niphuis, Roja Fidel Acar, Ivanela Kondova, Yolanda S. Kap, Willy M. J. M. Bogers, Petra Mooij & Sylvain Fleury. (2023) A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge. Scientific Reports 13:1.
Crossref
Crossref
Fuhua Wu, Ming Qin, Hairui Wang & Xun Sun. (2022) Nanovaccines to combat virus‐related diseases. WIREs Nanomedicine and Nanobiotechnology 15:2.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
Marcel Franco Mougenot, Vanessa Sousa Pereira, Ana Letícia Rodrigues Costa, Marcelo Lancellotti, Marimelia Aparecida Porcionatto, Juliano Coelho da Silveira & Lucimara Gaziola de la Torre. (2022) Biomimetic Nanovesicles—Sources, Design, Production Methods, and Applications. Pharmaceutics 14:10, pages 2008.
Crossref
Crossref
Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, Patrícia Gomes-Alves, Toon Stegmann, Mario Amacker, Paula M. Alves, Sylvain Fleury & António Roldão. (2022) Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate. Pharmaceutics 14:4, pages 854.
Crossref
Crossref
Daniel P. Leaman, Armando Stano, Yajing Chen, Lei Zhang & Michael B. Zwick. (2021) Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes. Journal of Virology 95:13.
Crossref
Crossref
Wandi Zhu, Chunhong Dong, Lai Wei & Bao-Zhong Wang. (2021) Promising Adjuvants and Platforms for Influenza Vaccine Development. Pharmaceutics 13:1, pages 68.
Crossref
Crossref
Sukhbir Singh, Neelam Sharma, Anil Bansal, Neha Kanojia, Sheshank Sethi, Jitender Madan & Rupinder Kaur Sodhi. 2021. Clinical Perspectives and Targeted Therapies in Apoptosis. Clinical Perspectives and Targeted Therapies in Apoptosis
153
207
.
Azadeh Alishahi, Mohsen Zargar, Amir Ghaemi, Fatemeh Fotouhi & Mohammad Reza Zolfaghari. (2020) Design, Production, and Evaluation of Virosomes from H1N1 Influenza Virus. Iranian South Medical Journal 23:5, pages 442-454.
Crossref
Crossref
Hitesh Kumar Dewangan. (2020) Rational application of nanoadjuvant for mucosal vaccine delivery system. Journal of Immunological Methods 481-482, pages 112791.
Crossref
Crossref
Mario Amacker, Charli Smardon, Laura Mason, Jack Sorrell, Kirk Jeffery, Michael Adler, Farien Bhoelan, Olga Belova, Mark Spengler, Beena Punnamoottil, Markus Schwaller, Olivia Bonduelle, Behazine Combadière, Toon Stegmann, Andrew Naylor, Richard Johnson, Desmond Wong & Sylvain Fleury. (2020) New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes. npj Vaccines 5:1.
Crossref
Crossref
Atin Khalaj‐Hedayati, Caroline Lin Lin Chua, Peter Smooker & Khai Wooi Lee. (2019) Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement. Influenza and Other Respiratory Viruses 14:1, pages 92-101.
Crossref
Crossref
Shailendra K. Saxena, Vimal K. Maurya, Swatantra Kumar & Madan L.B. Bhatt. 2020. Genomics and Biotechnological Advances in Veterinary, Poultry, and Fisheries. Genomics and Biotechnological Advances in Veterinary, Poultry, and Fisheries
421
433
.
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2020. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
285
315
.
Yadira Lobaina Mato. (2019) Nasal route for vaccine and drug delivery: Features and current opportunities. International Journal of Pharmaceutics 572, pages 118813.
Crossref
Crossref
Ruth M. Ruprecht, Bishal Marasini & Rajesh Thippeshappa. (2019) Mucosal Antibodies: Defending Epithelial Barriers against HIV-1 Invasion. Vaccines 7:4, pages 194.
Crossref
Crossref
Mingyuan Li, Chunyang Du, Na Guo, Yuou Teng, Xin Meng, Hua Sun, Shuangshuang Li, Peng Yu & Hervé Galons. (2019) Composition design and medical application of liposomes. European Journal of Medicinal Chemistry 164, pages 640-653.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2018. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
1
31
.
Diane McMahon-Pratt. 2019. Immunoepidemiology. Immunoepidemiology
245
264
.
Wooyoung Jeon, Yeu-Chun Kim, Minhee Hong, Sanoj Rejinold, Kyoungmoon Park, Injoong Yoon, Sungsik Yoo, Hongweon Lee & Jungoh Ahn. (2018) Microcrystalline Cellulose for Delivery of Recombinant Protein-Based Antigen against Erysipelas in Mice. BioMed Research International 2018, pages 1-7.
Crossref
Crossref
Blaise Corthésy & Gilles Bioley. (2018) Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Frontiers in Immunology 9.
Crossref
Crossref
R.L.B. Costa, H. Soliman & B.J. Czerniecki. (2017) The clinical development of vaccines for HER2 + breast cancer: Current landscape and future perspectives. Cancer Treatment Reviews 61, pages 107-115.
Crossref
Crossref
Viraj Kulkarni & Ruth M. Ruprecht. (2017) Mucosal IgA Responses: Damaged in Established HIV Infection—Yet, Effective Weapon against HIV Transmission. Frontiers in Immunology 8.
Crossref
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de Voorde. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production
1
16
.
Sharan Bobbala & Sarah Hook. (2016) Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?. Pharmaceutical Research 33:9, pages 2078-2097.
Crossref
Crossref
Christopher J.H. Davitt & Ed C. Lavelle. (2015) Delivery strategies to enhance oral vaccination against enteric infections. Advanced Drug Delivery Reviews 91, pages 52-69.
Crossref
Crossref
Sujin LeeMinh Trang Nguyen. (2015) Recent Advances of Vaccine Adjuvants for Infectious Diseases. Immune Network 15:2, pages 51.
Crossref
Crossref
Viktoriya Sokolova, Astrid Maria Westendorf, Jan Buer, Klaus Überla & Matthias Epple. (2015) The potential of nanoparticles for the immunization against viral infections. Journal of Materials Chemistry B 3:24, pages 4767-4779.
Crossref
Crossref
Mark Spengler, Michael Adler & Christof M. Niemeyer. (2015) Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. The Analyst 140:18, pages 6175-6194.
Crossref
Crossref
Basavaraj K. Nanjwade. (2014) Nanotechnology Based Virosomal Drug Delivery Systems. Journal of Nanotechnology and Materials Science 1:1, pages 1-9.
Crossref
Crossref
Beatrice O. Ondondo. (2014) The influence of delivery vectors on HIV vaccine efficacy. Frontiers in Microbiology 5.
Crossref
Crossref
Asghar Abdoli, Hoorieh Soleimanjahi, Masoumeh Tavassoti Kheiri, Abbas Jamali, Vahideh Mazaheri & Meghdad Abdollahpour Alitappeh. (2014) An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice. Pathogens and Disease, pages n/a-n/a.
Crossref
Crossref
Nadia Chanzu & Beatrice Ondondo. (2014) Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy. Frontiers in Immunology 5.
Crossref
Crossref
B. Garulli, G. Di Mario, M. G. Stillitano, D. Compagnoni, F. Titti, A. Cafaro, B. Ensoli, Y. Kawaoka & M. R. Castrucci. (2014)
Induction of Antibodies and T Cell Responses by a Recombinant Influenza Virus Carrying an HIV-1 Tat
Protein in Mice
. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Philipp Heller, David Huesmann, Martin Scherer & Matthias Barz. 2014. Molecular Vaccines. Molecular Vaccines
643
671
.
Geert Leroux-Roels, Cathy Maes, Frédéric Clement, Frank van Engelenburg, Marieke van den Dobbelsteen, Michael Adler, Mario Amacker, Lucia Lopalco, Morgane Bomsel, Anick Chalifour & Sylvain Fleury. (2013) Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS ONE 8:2, pages e55438.
Crossref
Crossref
Christian Moser & Mario Amacker. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
287
307
.
Kim A. WoodrowKaila M. Bennett & David D. Lo. (2012) Mucosal Vaccine Design and Delivery. Annual Review of Biomedical Engineering 14:1, pages 17-46.
Crossref
Crossref
Bryce Chackerian & John T. Schiller. 2012. Vaccinology. Vaccinology
196
208
.
Nathalie Garçon, Sandra Morel, Arnaud Didierlaurent, Dominique Descamps, Martine Wettendorff & Marcelle Van Mechelen. (2011) Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach. BioDrugs 25:4, pages 217-226.
Crossref
Crossref
Gerd Lipowsky & Martin F. Bachmann. 2011. Development of Vaccines. Development of Vaccines
19
63
.
Marie-Luce De Temmerman, Joanna Rejman, Jo Demeester, Darrell J. Irvine, Bruno Gander & Stefaan C. De Smedt. (2011) Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discovery Today 16:13-14, pages 569-582.
Crossref
Crossref
Morgane Bomsel, Daniela Tudor, Anne-Sophie Drillet, Annette Alfsen, Yonatan Ganor, Marie-Gaëlle Roger, Nicolas Mouz, Mario Amacker, Anick Chalifour, Lorenzo Diomede, Gilles Devillier, Zhe Cong, Qiang Wei, Hong Gao, Chuan Qin, Gui-Bo Yang, Rinaldo Zurbriggen, Lucia Lopalco & Sylvain Fleury. (2011) Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges. Immunity 34:2, pages 269-280.
Crossref
Crossref
Bruno Garulli, Giuseppina Di Mario, Ester Sciaraffia, Yoshihiro Kawaoka & Maria R. Castrucci. (2011) Immunogenicity of a Recombinant Influenza Virus Bearing Both the CD4+ and CD8+ T Cell Epitopes of Ovalbumin. Journal of Biomedicine and Biotechnology 2011, pages 1-7.
Crossref
Crossref
Patrick A. Bovier, Jürgen Bock, Tiziana Farinelli Ebengo, Gert Frösner, Jacqueline Glaus, Christian Herzog & Louis Loutan. (2010) Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine. Journal of Medical Virology 82:10, pages 1629-1634.
Crossref
Crossref
Carolyn Driver. (2010) Criteria for choosing hepatitis A vaccine. Practice Nursing 21:9, pages 479-482.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Olga Borges, Filipa Lebre, Dulce Bento, Gerrit Borchard & Hans E. Junginger. (2009) Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers. Pharmaceutical Research 27:2, pages 211-223.
Crossref
Crossref
T. Ebensen, B. Fuchs, K. Schulze & C. A. Guzmán. 2010. Handbook of Hydrocarbon and Lipid Microbiology. Handbook of Hydrocarbon and Lipid Microbiology
3311
3331
.
Nadja Kopp, Diana Diaz, Mario Amacker, David O. Odongo, Konstantin Beier, Cordula Nitsch, Richard P. Bishop & Claudia A. Daubenberger. (2009) Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologues. Vaccine 28:1, pages 261-269.
Crossref
Crossref
Mario Amacker, Stefan Moese, Andreas R. Kammer, Ari Helenius & Rinaldo Zurbriggen. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals
377
393
.
Gian Vincenzo Zuccotti, Andrea Scaramuzza, Sara Riboni, Chiara Mameli, Elena Pariani, Elisabetta Tanzi, Alessandro Zanetti & Giovanni Radaelli. (2009) Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Vaccine 27:39, pages 5357-5362.
Crossref
Crossref
Christian Herzog, Katharina Hartmann, Valérie Künzi, Oliver Kürsteiner, Robert Mischler, Hedvika Lazar & Reinhard Glück. (2009) Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine. Vaccine 27:33, pages 4381-4387.
Crossref
Crossref
Valérie Künzi, Jaco M. Klap, Michael K. Seiberling, Christian Herzog, Katharina Hartmann, Oliver Kürsteiner, Ronald Kompier, Roberto Grimaldi & Jaap Goudsmit. (2009) Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. Vaccine 27:27, pages 3561-3567.
Crossref
Crossref
Robert L. Atmar & Wendy A. Keitel. 2009. Vaccines for Pandemic Influenza. Vaccines for Pandemic Influenza
323
344
.
Pamela Hamill, Kelly Brown, Håvard Jenssen & Robert EW Hancock. (2008) Novel anti-infectives: is host defence the answer?. Current Opinion in Biotechnology 19:6, pages 628-636.
Crossref
Crossref
Karin Riedl, Rosemarie Riedl, Alexander von Gabain, Eszter Nagy & Karen Lingnau. (2008) The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice. Vaccine 26:27-28, pages 3461-3468.
Crossref
Crossref